Malignant melanoma continues to cause concern. Its incidence and mortality is increasing in most countries studied. Depletion of the ozone layer in the northern hemisphere has led to disturbing predictions that this trend will continue for all forms of skin cancer well into the next century (Mackie, 1988) .
Previous studies (Gordon & Lowry, 1986a) indicated that the incidence of malignant melanoma in Northern Ireland is similar to that found in other population-based studies, although lower than reported in Norway or Australia. A female to male ratio of approximately three to one was noted in the province, the highest sex ratio so far reported in the literature. The distribution of histopathological types was also unusual with a lower incidence of Superficial Spreading Melanoma, SSM (27%), than reported elsewhere, and relatively higher proportions of Nodular Melanoma, NM (42%), Lentigo Maligna Melanoma, LMM (20%), and Acral Lentiginous Melanoma, ALM (11%). More worrying was the finding that patients in Northern Ireland presented with more advanced disease than in any other major incidence study. This is usually related to the clinical stage of the disease.
Unfortunately this clinical information was often not available in this retrospective survey, and advanced disease was therefore defined by the Breslow thickness of the lesion. Sixty-seven per cent of lesions were thicker than 1.7mm; alternatively 75% of lesions were thicker than 1.5 mm. Both of these thicknesses have been described as 'natural break points'. The current study was biopsy specimens were submitted to these centres. Details on the methodology were given in the previous incidence study (Gordon & Lowry, 1986a (Kaplan & Meier, 1958) . Initial univariate analysis using the log rank test (Peto, 1977) Of the 32 deaths (26%) whose primary cause of death was not given as melanoma, 27 deaths were due to cardiovascular disease, three to unrelated carcinoma, one to pulmonary embolus and one unknown. These 32 patients belonged predominantly to the older age bands, 14 being over 80 years and a further 11 over 70 years. It is possible that some of these deaths were also due to melanoma although this may not have been recognised at the time. Profile Tumour profile provides an independent indication of survival in this population. When adjusted for Breslow measurement, profile becomes highly significant (P<0.001) and remains so after further adjustment for age and site. In contrast to univariate analysis, flat profile tumours have the worst prognosis, given their thickness, followed by convex/ plateau and then polypoidal/pedunculated lesions. Flat melanomas therefore have a higher risk than their thickness would suggest. In this study 47% of flat profile tumours are thin (< 0.76 mm), and 37% are thick (> 1.7 mm) with 30% greater than 4 mm thickness.
Age Age is a significant independent prognostic factor in survival. Adjustment for thickness reduces the significance of age because older patients tend to have thicker lesions. The relative hazard for age shows a 24% increase in risk per decade of age at diagnosis.
Sex Although females in Northern Ireland fare marginally better than males in univariate analyses, multivariate analysis shows that sex is not independently significant. The superiority in female survival can be explained by the high proportion of female tumours occurring on the lower limb (33% female, 12% males) and the greater proportion of males with lesions thicker than 1.7 mm (82% males, 62% females).
Site Site remains significant when adjusted individually for all other factors except tumour type. After simultaneous adjustment for age, type and Breslow measurement however, site is not significant. This adjustment reduces the risk of tumours of the foot to that of the head and neck. Thus the poor prognosis for lesions of the foot can be explained by the fact that they not only tend to be thick lesions occurring in older patients, but more importantly because the majority are ALM lesions.
Other features Cell type and pigmentation are of no independent prognostic value.
Conclusion
In conclusion five features make a statistically significant independent contribution to survival in this study. These are: (i) Thickness in millimetres.
(ii) Ulceration.
(iii) Histopathological type.
(iv) Tumour profile.
(v) Age. (Breslow, 1970; Mackie et al., 1985) .
Thickness linked to diagnostic delay has been proposed as the reason for poor prognosis in Britain and in Ireland (Doherty & Mackie, 1986) .
Ulceration has also been associated with poor prognosis (Balch et al., 1980) . In the present study, ulceration denotes a particularly aggressive lesion. Histological sub-type is important. ALM has the worst prognosis in both univariate and multivariate analysis, suggesting that this is due to the aggressive nature of this tumour type, rather than the difficulty in diagnosing less visually accessible lesions. Although numbers are small, the adequacy of the estimate is shown by the confidence limits in Table II . These are quite wide reflecting the small proportion of patients with ALM. In keeping with other studies, LMM has the best prognosis (Larsen & Grude, 1986) . This advantage is unfortunately offset by the thickness of many LMM's in the province.
Some studies have suggested that profile is not significant once thickness is taken into account. However our study indicates that profile is important. Although univariate analysis suggests that polypoid tumours fare worse, in multivariate analysis flat tumours have the worst prognosis when their thickness is taken into account. Regression may partly account for this finding. It has been suggested that thin tumours less than 0.76mm showing evidence of regression have a poor prognosis (Gromet et al., 1978; Shaw et al., 1980) . However flat lesions are not necessarily'thin. In fact less than half the flat tumours in this study are thin. Unfortunately however the importance of regression as a covariate was not widely recognised when this study was initiated and it was not recorded.
Age is a weak but significant independent prognostic factor. This could be due to less aggressive treatment in the elderly, perhaps associated with less resistance to disease. Studies indicate that ultra violet radiation suppresses immune defence mechanisms and this may be more pronounced in older patients.
Females survive longer not because they are females, but because they have relatively thin lesions on the lower leg. It may be that it is not their sex that makes the difference but their behaviour. Women dress differently from men, are more aware of skin blemishes, and presumably attend their doctor more promptly. But if females have earlier lesions, they unfortunately have more lesions. The increased incidence of malignant melanoma in women in Ireland may also be related to behavioural differences between the sexes and attitudes to sun tanning. The three to one female to male melanoma ratio has recently been noted in separate studies in Dublin and Cork in the Republic of Ireland (O'Loughlin et al., 1989) .
The finding that prognosis is determined by type and profile may be linked to the progression of the disease. The relative role of different aetiological factors will depend on the weighting of these factors in different populations. The examination of many variables can make interpretation difficult as there is always the possibility of type I error. However this is 'Unlikely in the present study as all the variables in the final model are significant to the 1% level or better. The model is nonetheless idiosyncratic. It is generated from an unusual group of patients, 67% of whom have lesions thicker than 1.7 mm at presentation. Moreover, the unusually high female to male sex ratio distribution has not been noted outside Ireland, and the distribution of histopathological types does not match that found elsewhere. The model is therefore primarily applicable to Northern Ireland. In addition, not all the important variables were available for analysis in this retrospective study. As already noted, clinical stage was unfortunately often not recorded at the time of the study. In retrospect it is likely that a population with such late presentation would have had a relatively high proportion of Stage II or Stage III disease.
It is regretted that this important variable was not included. Not surprisingly it has been shown that the risk of dying from melanoma in Stage II-III disease is much greater than in Stage I disease. Information on stage is being collected in a current study covering the subsequent decade, bearing in mind that the level of clinical, surgical and pathological staging in any form of cancer is, to some extent, a measure of the intensity of the clinical investigations performed. Inevitably some patients with so-called Stage I disease will have small undetected metastases. An unstaged series is of some value, but it does limit the comparability of this investigation.
Again, the value of mitotic activity was not clearly defined when the study was initiated. The idiosyncratic features of the population and the impact of the additional variables are recognised. For instance the influence of sex on prognosis might be expected to be different for Stage I and Stage II disease. However it is difficult to speculate on the exact influence of these additional variables in any precise way. Information on mitotic activity is also now being collected in a current study covering the subsequent decade. Finally it was not considered necessary to test the model in a 'hold back' sample. The use of a 'hold back' sample or 'test set' is not standard practice in survival analysis, although it is so in discriminant function analysis in which predictions or allocations are made. We chose to model the results primarily to improve understanding of the relationship between the covariates and survival rather than to make predictions. The inclusion of a 'hold back' sample would have led to a reduction in the precision of relative hazard estimates.
In conclusion the reduced survival for melanoma in Northern Ireland fits the poor overall health pattern found for other diseases in the province. Socio-economic factors have been blamed for much of this morbidity and mortality, but cannot entirely account for the dismal prognosis with melanoma. National Health Service facilities are available for all patients to receive prompt treatment for skin cancer.
Northern Ireland has a maritime climate and lies between 54°N-56°N. In common with Scandinavia and Scotland at similar latitudes there has been a 6-7% depletion in the ozone layer since 1970, and a consequent increase in the ultraviolet flux (NASA, 1988) . This factor along with the Celtic skin type, the greater availability of sunbeds and package holidays, the sun-tan 'status symbol', the general lack of awareness of the dangers of solar skin damage, and diagnostic delay have all contributed to the problem of melanoma in Northern Ireland. Equally worrying is the lack of professional awareness leading to diagnostic delay by doctors in some cases (Gordon & Lowry, 1986b) . The cumulative results of all these factors are clearly demonstrated in this study. The extent to which these findings apply will vary from country to country. In Northern Ireland educational intervention is essential if the present trend is to be reversed.
